Get the Stockscreener App
1.03
0.96%
-0.01
After Hours:
1.04
0.01
+0.97%
Vivani Medical Inc stock is traded at $1.03, with a volume of 52,712.
It is down -0.96% in the last 24 hours and up +0.98% over the past month.
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.
See More
Previous Close:
$1.04
Open:
$1.05
24h Volume:
52,712
Relative Volume:
0.67
Market Cap:
$61.02M
Revenue:
-
Net Income/Loss:
$-25.65M
P/E Ratio:
-2.102
EPS:
-0.49
Net Cash Flow:
$-24.59M
1W Performance:
+0.00%
1M Performance:
+0.98%
6M Performance:
-17.60%
1Y Performance:
-43.09%
1-Day Range:
$1.02
$1.05
1-Week Range:
$1.02
$1.05
52-Week Range:
$0.9054
$2.09
Vivani Medical Inc Stock (VANI) Company Profile
Name
Vivani Medical Inc
Sector
Industry
Phone
818-833-5000
Address
1350 S. LOOP ROAD, ALAMEDA
Compare VANI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VANI
Vivani Medical Inc
|
1.03 | 61.02M | 0 | -25.65M | -24.59M | -0.49 |
|
VRTX
Vertex Pharmaceuticals Inc
|
439.37 | 128.45B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
575.63 | 65.17B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
560.90 | 40.09B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
270.19 | 35.67B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
233.25 | 27.44B | 3.81B | -644.79M | -669.77M | -6.24 |
Vivani Medical Inc Stock (VANI) Latest News
Vivani Medical (VANI) to Release Quarterly Earnings on Monday - MarketBeat
Vivani Medical (VANI) to Release Earnings on Monday - Defense World
Vivani Medical to Present at the American Association of - GlobeNewswire
Vivani Medical to Present at the American Association of Pharmaceutical Scientists' 'Beyond GLP1s: Where the Science will Take Business Next” Virtual Workshop - The Manila Times
Vivani Medical to Present at the American Association of Pharmaceutical Scientists’ “Beyond GLP1s: Where the Science will Take Business Next” Virtual Workshop - Yahoo Finance
Vivani Medical director Gregg Williams buys $1,124 in stock - Investing.com
Vivani Medical director Gregg Williams buys $1,124 in stock By Investing.com - Investing.com South Africa
Vivani Medical, Inc. (NASDAQ:VANI) Short Interest Update - MarketBeat
Vivani Medical Advances Drug Delivery Innovation with NanoPortal Technology - morgannewspaper.com
Vivani Medical's (VANI) Buy Rating Reiterated at HC Wainwright - MarketBeat
Head-To-Head Comparison: Nexeon Medsystems (OTCMKTS:NXNN) and Vivani Medical (NASDAQ:VANI) - Defense World
Vivani Medical’s (VANI) “Buy” Rating Reiterated at HC Wainwright - Defense World
Vivani Medical to Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & Company - The Manila Times
Vivani Medical expands partnership with Okava for dog therapy By Investing.com - Investing.com South Africa
EXCLUSIVE: Vivani Medical Collaborates With Okava To Expand Development Of GLP-1 Therapy For Dogs - AOL.com
Vivani Medical And Okava Expand Collaboration To Develop Okv-119 For Dogs, Targeting Metabolic Health And Longevity - marketscreener.com
Vivani Medical expands partnership with Okava for dog therapy - Investing.com
Vivani Medical and Okava Expand Collaboration to Develop - GlobeNewswire
Vivani Medical and Okava Expand Collaboration to Develop OKV-119 for Dogs, Targeting Metabolic Health and Longevity - Yahoo Finance
Insider Buying: Vivani Medical, Inc. (NASDAQ:VANI) Director Buys 44,400 Shares of Stock - MarketBeat
Vivani medical director Gregg Williams invests $21,233 in shares By Investing.com - Investing.com Australia
Vivani medical director Gregg Williams buys $21,233 in stock By Investing.com - Investing.com UK
Insider Buying: Vivani Medical, Inc. (NASDAQ:VANI) Director Buys 34,000 Shares of Stock - MarketBeat
HC Wainwright Reiterates "Buy" Rating for Vivani Medical (NASDAQ:VANI) - MarketBeat
Vivani Medical's director Gregg Williams acquires $205k in stock - Investing.com Australia
Vivani Medical’s director Gregg Williams acquires $205k in stock - Investing.com
Vivani Medical’s director Gregg Williams acquires $205k in stock By Investing.com - Investing.com South Africa
Vivani Medical's director Gregg Williams acquires $205k in stock By Investing.com - Investing.com India
Vivani Medical Director Gregg Williams Acquires Over 200K Shares - TradingView
Vivani Medical Announces Positive Preclinical Liver Fat Results with Miniature, Ultra Long-Acting GLP-1 Implant - MarketScreener
Vivani Medical (NASDAQ:VANI) Earns Buy Rating from HC Wainwright - Defense World
Vivani medical director Gregg Williams buys $24,959 in stock - Investing.com Australia
Vivani medical director Gregg Williams buys $24,959 in stock By Investing.com - Investing.com UK
Insider Purchases Worth US$5.02m See Losses As Vivani Medical Market Value Drops To US$60m - simplywall.st
H.C. Wainwright maintains Buy on Vivani Medical stock, $4 target By Investing.com - Investing.com Canada
H.C. Wainwright maintains Buy on Vivani Medical stock, $4 target - Investing.com
Vivani medical chief business officer purchases $4,100 in shares By Investing.com - Investing.com South Africa
Vivani medical chief business officer purchases $4,100 in shares - Investing.com India
Vivani Medical Inc Stock (VANI) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):